Phase 1 Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men between the ages of 18 and 60, or women between the ages of 18 and 75, at the time of screening
- People who have been diagnosed with severe or very severe alopecia areata, meaning they have lost at least 50% of the hair on their scalp (including those with complete scalp hair loss, or complete loss of scalp, face, and body hair), confirmed by a standardised scoring method and photo review, with no other known cause of hair loss
Who may not be able to join:
- People whose hair loss is caused by a different type of condition, such as traction-related hair loss, scarring, stress-related shedding, hair-pulling disorder, chemotherapy, or male/female pattern baldness
- People who have other scalp conditions that could affect how their hair loss is assessed, such as psoriasis, skin inflammation, or a fungal scalp infection
- People who have an active illness affecting the whole body that is causing hair loss, such as lupus, thyroid inflammation, or certain other systemic conditions (confirm with trial site)
Important: There are additional criteria not listed here that the trial site will review. Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +61 3 7050 1941
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Incidence of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs); Change from Baseline of Severity of Alopecia Tool (SALT) score at Week 16.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.